Loading…
Accuracy of FDG-PET/CT in Colorectal Peritoneal Carcinomatosis: Potential Tool for Evaluation of Chemotherapeutic Response
Neoadjuvant chemotherapy may be administered to patients with peritoneal carcinomatosis (PC) of colorectal cancer (CRC) origin. This study evaluated the performance of fluorodeoxyglucose positron-emission tomography (FDG-PET)/computed tomography (CT) in detection of PC from CRC and correlated the mo...
Saved in:
Published in: | Anticancer research 2017-02, Vol.37 (2), p.929-934 |
---|---|
Main Authors: | , , , , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c344t-d6055766efbd4b4b3f87d13cb214128ac2d12ffaa16c8a97229445b5fde77fc43 |
---|---|
cites | |
container_end_page | 934 |
container_issue | 2 |
container_start_page | 929 |
container_title | Anticancer research |
container_volume | 37 |
creator | Liberale, Gabriel Lecocq, Céline Garcia, Camilo Muylle, Kristof Covas, Angélique Deleporte, Amélie Hendlisz, Alain Bouazza, Fikri El Nakadi, Issam Flamen, Patrick |
description | Neoadjuvant chemotherapy may be administered to patients with peritoneal carcinomatosis (PC) of colorectal cancer (CRC) origin. This study evaluated the performance of
fluorodeoxyglucose positron-emission tomography (FDG-PET)/computed tomography (CT) in detection of PC from CRC and correlated the most metabolically active quadrant with the most affected peritoneal area determined during surgery.
This retrospective study compared the performance of FDG-PET/CT for PC diagnosis in 26 patients with CRC with histopathologically-confirmed PC with a control group of 26 patients. An FDG-PET/CT score established for each patient diagnosed with PC was compared with the peritoneal cancer index (PCI) performed during surgery.
The sensitivity and specificity of FDG-PET/CT for PC detection were 85% (22/26) and 88% (23/26), respectively. The most scored quadrant by FDG-PET/CT corresponded to the most scored quadrant at surgery in 77.3%.
FDG-PET/CT may represent a useful tool for evaluating response to neoadjuvant chemotherapy in patients with PC of CRC origin. |
doi_str_mv | 10.21873/anticanres.11401 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1866693244</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1866693244</sourcerecordid><originalsourceid>FETCH-LOGICAL-c344t-d6055766efbd4b4b3f87d13cb214128ac2d12ffaa16c8a97229445b5fde77fc43</originalsourceid><addsrcrecordid>eNpFkEtLw0AUhQdRbK3-ADcySzdp55VM6k5iW4WCReo6TCZ3aCTJ1JmJUH-96UNd3QP3nMPhQ-iWkjGjqeQT1YZKq9aBH1MqCD1DQyqnNJIxJ-doSFhMIklIPEBX3n8QkiTTlF-iAUt7G4_FEH0_at05pXfYGjx_WkSr2XqSrXHV4szW1oEOqsYrcFWwLfQyU05XrW1UsL7yD3hlA_Qr-s_a2hob6_DsS9WdCpVt96XZBhobNuDUFrp-Ln4Dv7Wth2t0YVTt4eZ0R-h9Pltnz9HydfGSPS4jzYUIUZmQOJZJAqYoRSEKblJZUq4LRgVlqdKspMwYpWiiUzWVjE2FiIvYlCCl0YKP0P2xd-vsZwc-5E3lNdS1asF2Pqdp0nPhTOyt9GjVznrvwORbVzXK7XJK8gPy_B95fkDeZ-5O9V3RQPmX-GXMfwA_tYDp</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1866693244</pqid></control><display><type>article</type><title>Accuracy of FDG-PET/CT in Colorectal Peritoneal Carcinomatosis: Potential Tool for Evaluation of Chemotherapeutic Response</title><source>EZB Electronic Journals Library</source><creator>Liberale, Gabriel ; Lecocq, Céline ; Garcia, Camilo ; Muylle, Kristof ; Covas, Angélique ; Deleporte, Amélie ; Hendlisz, Alain ; Bouazza, Fikri ; El Nakadi, Issam ; Flamen, Patrick</creator><creatorcontrib>Liberale, Gabriel ; Lecocq, Céline ; Garcia, Camilo ; Muylle, Kristof ; Covas, Angélique ; Deleporte, Amélie ; Hendlisz, Alain ; Bouazza, Fikri ; El Nakadi, Issam ; Flamen, Patrick</creatorcontrib><description>Neoadjuvant chemotherapy may be administered to patients with peritoneal carcinomatosis (PC) of colorectal cancer (CRC) origin. This study evaluated the performance of
fluorodeoxyglucose positron-emission tomography (FDG-PET)/computed tomography (CT) in detection of PC from CRC and correlated the most metabolically active quadrant with the most affected peritoneal area determined during surgery.
This retrospective study compared the performance of FDG-PET/CT for PC diagnosis in 26 patients with CRC with histopathologically-confirmed PC with a control group of 26 patients. An FDG-PET/CT score established for each patient diagnosed with PC was compared with the peritoneal cancer index (PCI) performed during surgery.
The sensitivity and specificity of FDG-PET/CT for PC detection were 85% (22/26) and 88% (23/26), respectively. The most scored quadrant by FDG-PET/CT corresponded to the most scored quadrant at surgery in 77.3%.
FDG-PET/CT may represent a useful tool for evaluating response to neoadjuvant chemotherapy in patients with PC of CRC origin.</description><identifier>ISSN: 0250-7005</identifier><identifier>EISSN: 1791-7530</identifier><identifier>DOI: 10.21873/anticanres.11401</identifier><identifier>PMID: 28179354</identifier><language>eng</language><publisher>Greece</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Colorectal Neoplasms - diagnostic imaging ; Colorectal Neoplasms - pathology ; Colorectal Neoplasms - surgery ; Drug Therapy ; Female ; Fluorodeoxyglucose F18 ; Humans ; Male ; Middle Aged ; Neoadjuvant Therapy ; Outcome Assessment (Health Care) - methods ; Peritoneal Neoplasms - diagnostic imaging ; Peritoneal Neoplasms - secondary ; Positron Emission Tomography Computed Tomography - methods ; Reproducibility of Results ; Retrospective Studies ; Sensitivity and Specificity</subject><ispartof>Anticancer research, 2017-02, Vol.37 (2), p.929-934</ispartof><rights>Copyright© 2017, International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c344t-d6055766efbd4b4b3f87d13cb214128ac2d12ffaa16c8a97229445b5fde77fc43</citedby></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/28179354$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Liberale, Gabriel</creatorcontrib><creatorcontrib>Lecocq, Céline</creatorcontrib><creatorcontrib>Garcia, Camilo</creatorcontrib><creatorcontrib>Muylle, Kristof</creatorcontrib><creatorcontrib>Covas, Angélique</creatorcontrib><creatorcontrib>Deleporte, Amélie</creatorcontrib><creatorcontrib>Hendlisz, Alain</creatorcontrib><creatorcontrib>Bouazza, Fikri</creatorcontrib><creatorcontrib>El Nakadi, Issam</creatorcontrib><creatorcontrib>Flamen, Patrick</creatorcontrib><title>Accuracy of FDG-PET/CT in Colorectal Peritoneal Carcinomatosis: Potential Tool for Evaluation of Chemotherapeutic Response</title><title>Anticancer research</title><addtitle>Anticancer Res</addtitle><description>Neoadjuvant chemotherapy may be administered to patients with peritoneal carcinomatosis (PC) of colorectal cancer (CRC) origin. This study evaluated the performance of
fluorodeoxyglucose positron-emission tomography (FDG-PET)/computed tomography (CT) in detection of PC from CRC and correlated the most metabolically active quadrant with the most affected peritoneal area determined during surgery.
This retrospective study compared the performance of FDG-PET/CT for PC diagnosis in 26 patients with CRC with histopathologically-confirmed PC with a control group of 26 patients. An FDG-PET/CT score established for each patient diagnosed with PC was compared with the peritoneal cancer index (PCI) performed during surgery.
The sensitivity and specificity of FDG-PET/CT for PC detection were 85% (22/26) and 88% (23/26), respectively. The most scored quadrant by FDG-PET/CT corresponded to the most scored quadrant at surgery in 77.3%.
FDG-PET/CT may represent a useful tool for evaluating response to neoadjuvant chemotherapy in patients with PC of CRC origin.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Colorectal Neoplasms - diagnostic imaging</subject><subject>Colorectal Neoplasms - pathology</subject><subject>Colorectal Neoplasms - surgery</subject><subject>Drug Therapy</subject><subject>Female</subject><subject>Fluorodeoxyglucose F18</subject><subject>Humans</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neoadjuvant Therapy</subject><subject>Outcome Assessment (Health Care) - methods</subject><subject>Peritoneal Neoplasms - diagnostic imaging</subject><subject>Peritoneal Neoplasms - secondary</subject><subject>Positron Emission Tomography Computed Tomography - methods</subject><subject>Reproducibility of Results</subject><subject>Retrospective Studies</subject><subject>Sensitivity and Specificity</subject><issn>0250-7005</issn><issn>1791-7530</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2017</creationdate><recordtype>article</recordtype><recordid>eNpFkEtLw0AUhQdRbK3-ADcySzdp55VM6k5iW4WCReo6TCZ3aCTJ1JmJUH-96UNd3QP3nMPhQ-iWkjGjqeQT1YZKq9aBH1MqCD1DQyqnNJIxJ-doSFhMIklIPEBX3n8QkiTTlF-iAUt7G4_FEH0_at05pXfYGjx_WkSr2XqSrXHV4szW1oEOqsYrcFWwLfQyU05XrW1UsL7yD3hlA_Qr-s_a2hob6_DsS9WdCpVt96XZBhobNuDUFrp-Ln4Dv7Wth2t0YVTt4eZ0R-h9Pltnz9HydfGSPS4jzYUIUZmQOJZJAqYoRSEKblJZUq4LRgVlqdKspMwYpWiiUzWVjE2FiIvYlCCl0YKP0P2xd-vsZwc-5E3lNdS1asF2Pqdp0nPhTOyt9GjVznrvwORbVzXK7XJK8gPy_B95fkDeZ-5O9V3RQPmX-GXMfwA_tYDp</recordid><startdate>20170201</startdate><enddate>20170201</enddate><creator>Liberale, Gabriel</creator><creator>Lecocq, Céline</creator><creator>Garcia, Camilo</creator><creator>Muylle, Kristof</creator><creator>Covas, Angélique</creator><creator>Deleporte, Amélie</creator><creator>Hendlisz, Alain</creator><creator>Bouazza, Fikri</creator><creator>El Nakadi, Issam</creator><creator>Flamen, Patrick</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20170201</creationdate><title>Accuracy of FDG-PET/CT in Colorectal Peritoneal Carcinomatosis: Potential Tool for Evaluation of Chemotherapeutic Response</title><author>Liberale, Gabriel ; Lecocq, Céline ; Garcia, Camilo ; Muylle, Kristof ; Covas, Angélique ; Deleporte, Amélie ; Hendlisz, Alain ; Bouazza, Fikri ; El Nakadi, Issam ; Flamen, Patrick</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c344t-d6055766efbd4b4b3f87d13cb214128ac2d12ffaa16c8a97229445b5fde77fc43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2017</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Colorectal Neoplasms - diagnostic imaging</topic><topic>Colorectal Neoplasms - pathology</topic><topic>Colorectal Neoplasms - surgery</topic><topic>Drug Therapy</topic><topic>Female</topic><topic>Fluorodeoxyglucose F18</topic><topic>Humans</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neoadjuvant Therapy</topic><topic>Outcome Assessment (Health Care) - methods</topic><topic>Peritoneal Neoplasms - diagnostic imaging</topic><topic>Peritoneal Neoplasms - secondary</topic><topic>Positron Emission Tomography Computed Tomography - methods</topic><topic>Reproducibility of Results</topic><topic>Retrospective Studies</topic><topic>Sensitivity and Specificity</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Liberale, Gabriel</creatorcontrib><creatorcontrib>Lecocq, Céline</creatorcontrib><creatorcontrib>Garcia, Camilo</creatorcontrib><creatorcontrib>Muylle, Kristof</creatorcontrib><creatorcontrib>Covas, Angélique</creatorcontrib><creatorcontrib>Deleporte, Amélie</creatorcontrib><creatorcontrib>Hendlisz, Alain</creatorcontrib><creatorcontrib>Bouazza, Fikri</creatorcontrib><creatorcontrib>El Nakadi, Issam</creatorcontrib><creatorcontrib>Flamen, Patrick</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Anticancer research</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Liberale, Gabriel</au><au>Lecocq, Céline</au><au>Garcia, Camilo</au><au>Muylle, Kristof</au><au>Covas, Angélique</au><au>Deleporte, Amélie</au><au>Hendlisz, Alain</au><au>Bouazza, Fikri</au><au>El Nakadi, Issam</au><au>Flamen, Patrick</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Accuracy of FDG-PET/CT in Colorectal Peritoneal Carcinomatosis: Potential Tool for Evaluation of Chemotherapeutic Response</atitle><jtitle>Anticancer research</jtitle><addtitle>Anticancer Res</addtitle><date>2017-02-01</date><risdate>2017</risdate><volume>37</volume><issue>2</issue><spage>929</spage><epage>934</epage><pages>929-934</pages><issn>0250-7005</issn><eissn>1791-7530</eissn><abstract>Neoadjuvant chemotherapy may be administered to patients with peritoneal carcinomatosis (PC) of colorectal cancer (CRC) origin. This study evaluated the performance of
fluorodeoxyglucose positron-emission tomography (FDG-PET)/computed tomography (CT) in detection of PC from CRC and correlated the most metabolically active quadrant with the most affected peritoneal area determined during surgery.
This retrospective study compared the performance of FDG-PET/CT for PC diagnosis in 26 patients with CRC with histopathologically-confirmed PC with a control group of 26 patients. An FDG-PET/CT score established for each patient diagnosed with PC was compared with the peritoneal cancer index (PCI) performed during surgery.
The sensitivity and specificity of FDG-PET/CT for PC detection were 85% (22/26) and 88% (23/26), respectively. The most scored quadrant by FDG-PET/CT corresponded to the most scored quadrant at surgery in 77.3%.
FDG-PET/CT may represent a useful tool for evaluating response to neoadjuvant chemotherapy in patients with PC of CRC origin.</abstract><cop>Greece</cop><pmid>28179354</pmid><doi>10.21873/anticanres.11401</doi><tpages>6</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0250-7005 |
ispartof | Anticancer research, 2017-02, Vol.37 (2), p.929-934 |
issn | 0250-7005 1791-7530 |
language | eng |
recordid | cdi_proquest_miscellaneous_1866693244 |
source | EZB Electronic Journals Library |
subjects | Adult Aged Aged, 80 and over Colorectal Neoplasms - diagnostic imaging Colorectal Neoplasms - pathology Colorectal Neoplasms - surgery Drug Therapy Female Fluorodeoxyglucose F18 Humans Male Middle Aged Neoadjuvant Therapy Outcome Assessment (Health Care) - methods Peritoneal Neoplasms - diagnostic imaging Peritoneal Neoplasms - secondary Positron Emission Tomography Computed Tomography - methods Reproducibility of Results Retrospective Studies Sensitivity and Specificity |
title | Accuracy of FDG-PET/CT in Colorectal Peritoneal Carcinomatosis: Potential Tool for Evaluation of Chemotherapeutic Response |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-07T10%3A27%3A32IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Accuracy%20of%20FDG-PET/CT%20in%20Colorectal%20Peritoneal%20Carcinomatosis:%20Potential%20Tool%20for%20Evaluation%20of%20Chemotherapeutic%20Response&rft.jtitle=Anticancer%20research&rft.au=Liberale,%20Gabriel&rft.date=2017-02-01&rft.volume=37&rft.issue=2&rft.spage=929&rft.epage=934&rft.pages=929-934&rft.issn=0250-7005&rft.eissn=1791-7530&rft_id=info:doi/10.21873/anticanres.11401&rft_dat=%3Cproquest_cross%3E1866693244%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c344t-d6055766efbd4b4b3f87d13cb214128ac2d12ffaa16c8a97229445b5fde77fc43%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1866693244&rft_id=info:pmid/28179354&rfr_iscdi=true |